DNA methylation of nuclear receptor genes—possible role in malignancy

[1]  B. Katzenellenbogen,et al.  Antiestrogens: Mechanisms of action and resistance in breast cancer , 1997, Breast Cancer Research and Treatment.

[2]  C. Osborne,et al.  Steroid hormone receptors in breast cancer management , 2004, Breast Cancer Research and Treatment.

[3]  S. Baylin,et al.  Dnmt3a and Dnmt3b Are Transcriptional Repressors That Exhibit Unique Localization Properties to Heterochromatin* , 2001, The Journal of Biological Chemistry.

[4]  H Ishii,et al.  Expression of mRNA for DNA methyltransferases and methyl‐CpG–binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis , 2001, Hepatology.

[5]  S. Hirohashi,et al.  DNA methyltransferase expression and DNA methylation of CPG islands and peri‐centromeric satellite regions in human colorectal and stomach cancers , 2001, International journal of cancer.

[6]  Qifeng Yang,et al.  Biallelic inactivation of retinoic acid receptor beta2 gene by epigenetic change in breast cancer. , 2001, The American journal of pathology.

[7]  J. Minna,et al.  Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas. , 2001, Journal of the National Cancer Institute.

[8]  Y. Miyoshi,et al.  Quantitative analysis of estrogen receptor‐β mRNA and its variants in human breast cancers , 2000, International journal of cancer.

[9]  P. Roland,et al.  Loss of estrogen receptor (ER) expression in endometrial tumors is not associated with de novo methylation of the 5' end of the ER gene. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[10]  R. Dahiya,et al.  Inactivation of the human androgen receptor gene is associated with CpG hypermethylation in uterine endometrial cancer , 2000, Molecular carcinogenesis.

[11]  P. Laird,et al.  Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. , 2000, Cancer research.

[12]  J. Herman,et al.  Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer. , 2000, Cancer research.

[13]  S. Baylin,et al.  DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci , 2000, Nature Genetics.

[14]  A. Friedl,et al.  Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer. , 2000, Cancer research.

[15]  M. Widschwendter,et al.  Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer. , 2000, Journal of the National Cancer Institute.

[16]  R H Hruban,et al.  Hypermethylation of multiple genes in pancreatic adenocarcinoma. , 2000, Cancer research.

[17]  S. Sukumar,et al.  Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor β2 promoter in breast cancer cells , 2000, Oncogene.

[18]  R. Dahiya,et al.  Frequent methylation of estrogen receptor in prostate cancer: correlation with tumor progression. , 2000, Cancer research.

[19]  J. Shimazaki,et al.  Assessment of hypermethylated DNA in two promoter regions of the estrogen receptor alpha gene in human endometrial diseases. , 2000, Gynecologic oncology.

[20]  S. Nass,et al.  Expression of DNA methyl-transferase (DMT) and the cell cycle in human breast cancer cells , 1999, Oncogene.

[21]  M. Toyota,et al.  CpG island methylator phenotypes in aging and cancer. , 1999, Seminars in cancer biology.

[22]  J. Issa,et al.  Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. , 1999, Cardiovascular research.

[23]  E. Li,et al.  Cloning, expression and chromosome locations of the human DNMT3 gene family. , 1999, Gene.

[24]  H. Iwata,et al.  DNA methylation analysis at distal and proximal promoter regions of the oestrogen receptor gene in breast cancers , 1999, British Journal of Cancer.

[25]  J. Herman,et al.  CpG island methylator phenotype in colorectal cancer. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[26]  C. Potten,et al.  Isoflavones inhibit intestinal epithelial cell proliferation and induce apoptosis in vitro , 1999, British Journal of Cancer.

[27]  D. Sinnett,et al.  DNA methylation of retinoic acid receptor beta in breast cancer and possible therapeutic role of 5-aza-2'-deoxycytidine. , 1999, Anti-cancer drugs.

[28]  P. Laird,et al.  CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. , 1999, Cancer research.

[29]  J. Issa,et al.  Estrogen receptor methylation is associated with improved survival in adult acute myeloid leukemia. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[30]  M. Hori,et al.  Hypermethylation of the estrogen receptor alpha gene is not related to lack of receptor protein in human breast cancer , 1999, Breast cancer.

[31]  H. Kawakami,et al.  Organization of the human orphan nuclear receptor Nurr1 gene. , 1999, Gene.

[32]  Peter A. Jones,et al.  Cancer-epigenetics comes of age , 1999, Nature Genetics.

[33]  S. Shany,et al.  The protective effect of estrogen against chemically induced murine colon carcinogenesis is associated with decreased CpG island methylation and increased mRNA and protein expression of the colonic vitamin D receptor. , 1999, Oncology research.

[34]  K. Robertson,et al.  The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. , 1999, Nucleic acids research.

[35]  K. Münger,et al.  Re-expression of endogenous p16ink4a in oral squamous cell carcinoma lines by 5-aza-2′-deoxycytidine treatment induces a senescence-like state , 1998, Oncogene.

[36]  J. Herman,et al.  Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells. , 1998, Cancer research.

[37]  S. Baylin,et al.  Aging and DNA methylation in colorectal mucosa and cancer. , 1998, Cancer research.

[38]  D. Sinnett,et al.  Demethylation by 5-aza-2´-deoxycytidine of specific 5-methylcytosine sites in the promoter region of the retinoic acid receptor ß gene in human colon carcinoma cells , 1998, Anti-cancer drugs.

[39]  T. Hashimshony,et al.  DNA methylation models histone acetylation , 1998, Nature.

[40]  S. Clark,et al.  Loss of p16INK4 expression by methylation is associated with lifespan extension of human mammary epithelial cells. , 1998, Cancer research.

[41]  A. Ferguson,et al.  Demethylation of the progesterone receptor CpG island is not required for progesterone receptor gene expression , 1998, Oncogene.

[42]  A. Brenner,et al.  Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation , 1998, Oncogene.

[43]  S. Baylin,et al.  Concordant methylation of the ER and N33 genes in glioblastoma multiforme , 1998, Oncogene.

[44]  S. Weitzman,et al.  Mapping of ER gene CpG island methylation-specific polymerase chain reaction. , 1998, Cancer research.

[45]  J. Lehmann,et al.  Cloning and Characterization of Human Estrogen Receptor β Isoforms , 1998 .

[46]  J. Strouboulis,et al.  Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription , 1998, Nature Genetics.

[47]  Colin A. Johnson,et al.  Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex , 1998, Nature.

[48]  V. Jordan,et al.  Methylation of CpG island is not a ubiquitous mechanism for the loss of oestrogen receptor in breast cancer cells. , 1998, British Journal of Cancer.

[49]  M. Widschwendter,et al.  Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer. , 1997, Cancer research.

[50]  S. Baylin.  Tying It All Together: Epigenetics, Genetics, Cell Cycle, and Cancer , 1997, Science.

[51]  H. Klocker,et al.  Metastatic lesions from prostate cancer do not express oestrogen and progesterone receptors , 1997, The Journal of pathology.

[52]  A. Wolffe,et al.  Histone acetylation: influence on transcription, nucleosome mobility and positioning, and linker histone‐dependent transcriptional repression , 1997, The EMBO journal.

[53]  R. Momparler,et al.  Activation of the retinoic acid receptor β gene by 5-aza-2’-deoxycytidine in human DLD-1 colon carcinoma cells , 1997, Anti-cancer drugs.

[54]  T. Therneau,et al.  Relationship between DNA ploidy and functional estrogen receptors in operable prostate cancer. , 1997, European urology.

[55]  J Isola,et al.  Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[56]  K. Burnstein,et al.  Androgenic up-regulation of androgen receptor cDNA expression in androgen-independent prostate cancer cells , 1996, Steroids.

[57]  S. Baylin,et al.  Methylation of the estrogen receptor CpG island in lung tumors is related to the specific type of carcinogen exposure. , 1996, Cancer research.

[58]  P. Gold,et al.  The human mineralocorticoid receptor gene promoter: Its structure and expression , 1996, The Journal of Steroid Biochemistry and Molecular Biology.

[59]  S. Weitzman,et al.  Methylation of estrogen and progesterone receptor gene 5' CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[60]  S. Baylin,et al.  The estrogen receptor CpG island is methylated in most hematopoietic neoplasms. , 1996, Cancer research.

[61]  John Calvin Reed,et al.  Retinoic acid receptor beta mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells , 1996, Molecular and cellular biology.

[62]  M. Szyf.  The DNA methylation machinery as a target for anticancer therapy. , 1996, Pharmacology & therapeutics.

[63]  S. Pradhan,et al.  DNA binding and methyl transfer catalysed by mouse DNA methyltransferase. , 1995, The Biochemical journal.

[64]  J. Herman,et al.  Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. , 1995, Cancer research.

[65]  R. Dickson,et al.  Growth factors in breast cancer. , 1995, Endocrine reviews.

[66]  A. L. Mazin.  Life span prediction from the rate of age-related dna demethylation in normal and cancer cell lines , 1995, Experimental Gerontology.

[67]  H. Klocker,et al.  Distant metastases from prostatic carcinoma express androgen receptor protein. , 1995, Cancer research.

[68]  J. Herman,et al.  5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers , 1995, Nature Medicine.

[69]  F. S. French,et al.  Androgen receptor defects : Historical, clinical, and molecular perspectives , 1995 .

[70]  S. Baylin,et al.  Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression. , 1995, Cancer research.

[71]  C. Schmidt,et al.  Changes of the methylation pattern of the c-myc gene during in vitro aging of IMR90 human embryonic fibroblasts. , 1995, Mutation research.

[72]  N. Roodi,et al.  Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer. , 1995, Journal of the National Cancer Institute.

[73]  S. Baylin,et al.  Stabilization of DNA methyltransferase levels and CpG island hypermethylation precede SV40-induced immortalization of human fibroblasts. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[74]  M. Pfahl,et al.  A specific defect in the retinoic acid response associated with human lung cancer cell lines. , 1994, Cancer research.

[75]  V. Fazio,et al.  The effect of tamoxifen and fenretinimide on human colorectal cancer cell lines in vitro. , 1994, Anticancer research.

[76]  R. Lotan,et al.  Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues. , 1994, Cancer research.

[77]  Y. Kanno,et al.  The mouse Rxrb gene encoding RXR beta: genomic organization and two mRNA isoforms generated by alternative splicing of transcripts initiated from CpG island promoters. , 1994, Gene.

[78]  S. Baylin,et al.  Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. , 1994, Cancer research.

[79]  H. Tsou,et al.  Down-Regulation of Retinoic Acid Receptor 3 in Mammary Carcinoma Cell Lines and Its Up-Regulation in Senescing Normal Mammary Epithelial Cells 1 , 2005 .

[80]  S. Baylin,et al.  Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon , 1994, Nature Genetics.

[81]  A. Bird,et al.  Number of CpG islands and genes in human and mouse. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[82]  J. Minna,et al.  Human lung cancer cell lines exhibit resistance to retinoic acid treatment. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[83]  N. Konishi,et al.  Immunohistochemical evaluation of estrogen receptor status in benign prostatic hypertrophy and in prostate carcinoma and the relationship to efficacy of endocrine therapy. , 1993, Oncology.

[84]  G. Adelmant,et al.  Characterization of a functional promoter for the human thyroid hormone receptor alpha (c-erbA-1) gene. , 1993, Oncogene.

[85]  W. Böcker,et al.  Relationship between quantity of silver stained nucleolar organizer region associated proteins (Ag-NORs) and growth rate suppression of breast cancer cell lines after interferon-gamma and 4-hydroxy-tamoxifen treatment , 1993, Virchows Archiv. B, Cell pathology including molecular pathology.

[86]  G. Kelsey,et al.  At least three promoters direct expression of the mouse glucocorticoid receptor gene. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[87]  A. Bird,et al.  Purification, sequence, and cellular localization of a novel chromosomal protein that binds to Methylated DNA , 1992, Cell.

[88]  L. Skoog,et al.  Immunohistochemistry and biochemistry in detection of androgen, progesterone, and estrogen receptors in benign and malignant human prostatic tissue , 1992, The Prostate.

[89]  S. Baylin,et al.  Abnormal patterns of DNA methylation in human neoplasia: potential consequences for tumor progression. , 1991, Cancer cells.

[90]  W. McGuire,et al.  Estrogen receptor gene methylation in human breast tumors. , 1990, Cancer research.

[91]  T. Ono,et al.  Age-dependent and tissue-specific changes of DNA methylation within and around the c-fos gene in mice. , 1989, Oncogene.

[92]  B. Katzenellenbogen,et al.  Ligand-modulated regulation of progesterone receptor messenger ribonucleic acid and protein in human breast cancer cell lines. , 1988, Molecular endocrinology.

[93]  R Holliday,et al.  The inheritance of epigenetic defects. , 1987, Science.

[94]  S. Baylin,et al.  DNA methylation patterns of the calcitonin gene in human lung cancers and lymphomas. , 1986, Cancer research.

[95]  T. Maloney,et al.  Evidence for a direct growth-stimulating effect of estradiol on human MCF-7 cells in vivo. , 1984, Cancer research.

[96]  M. Ehrlich,et al.  Amount and distribution of 5-methylcytosine in human DNA from different types of tissues of cells. , 1982, Nucleic acids research.

[97]  R Holliday,et al.  DNA modification mechanisms and gene activity during development , 1975, Science.